[{"NetIncomeLoss_1_Q2_USD":-61015000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-80000.0,"OperatingLeaseLiability_0_Q2_USD":16175000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":148982000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":20480000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":10907000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":94943000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":98459000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":7083000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":41000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":97600000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":35353000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":22.5,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":628000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":4274000.0,"AssetsCurrent_0_Q2_USD":366826000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":62046000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":23729000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":14522000.0,"SellingAndMarketingExpense_2_Q2_USD":37486000.0,"SellingAndMarketingExpense_1_Q2_USD":22250000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":4218000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":4178000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":98500000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-216000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":2043000.0,"Liabilities_0_Q2_USD":244138000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":13013000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":35233000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":19.4,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":18868000.0,"ValuationAllowancesAndReservesDeductions_2_Q2_USD":81506000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-1046000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-546000.0,"AccountsReceivableNetCurrent_0_Q2_USD":42615000.0,"CommonStockValue_0_Q2_USD":1019000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":7878000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":1473000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":875000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":14732000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":84000.0,"CostsAndExpenses_2_Q2_USD":155044000.0,"CostsAndExpenses_1_Q2_USD":82912000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":257700000.0,"IncreaseDecreaseInInventories_2_Q2_USD":895000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-113845000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-61095000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":10717000.0,"OtherAssetsNoncurrent_0_Q2_USD":346000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":191173000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":155612000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":66505000.0,"Assets_0_Q2_USD":404250000.0,"ShareBasedCompensation_2_Q2_USD":22727000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1506377000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":86035000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":765000.0,"AssetImpairmentCharges_2_Q2_USD":190000.0,"ProceedsFromConvertibleDebt_2_Q2_USD":148982000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":41000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":11241000.0,"ValuationAllowancesAndReservesBalance_0_Q2_USD":24436000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-104930000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":20985000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":4058000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":18307000.0,"LiabilitiesCurrent_0_Q2_USD":82143000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":191173000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":1529000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":23733000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":5500000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":30151000.0,"AdditionalPaidInCapital_0_Q2_USD":1665429000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":357839.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1529000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":22175000.0,"AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_1_Q2_USD":116000.0,"NetIncomeLoss_2_Q2_USD":-113629000.0,"AccountsPayableCurrent_0_Q2_USD":11242000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":73349000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":22443000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-178000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":14903000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":5101000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":2693000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":4379000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1783000.0,"OperatingIncomeLoss_2_Q2_USD":-112583000.0,"OperatingIncomeLoss_1_Q2_USD":-60469000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":66505000.0,"InventoryNet_0_Q2_USD":42800000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":42461000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":15.87,"LiabilitiesAndStockholdersEquity_0_Q2_USD":404250000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":13681000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":22727000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":11241000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":785000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3162000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.2,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.62,"StockholdersEquity_0_Q2_USD":160112000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1101000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":66464000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":15.51,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1979000.0,"Ticker":"HRTX","CIK":"818033","name":"HERON THERAPEUTICS, INC. \/DE\/","OfficialName":"Heron Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"558709361.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]